Literature DB >> 8151675

Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.

S F Yeo1, D M Livermore.   

Abstract

The effect of inoculum size on the results of agar dilution MIC tests was assessed for 20 Moraxella catarrhalis isolates with BRO-1 enzyme, 20 with BRO-2 enzyme and 15 isolates that did not produce beta-lactamase. The compounds tested were ampicillin, coamoxiclav, cefaclor, cefixime and cefetamet, and the inocula were 10(4), 10(5), 10(6) and 10(7) cfu/spot. The MICs of ampicillin for BRO-1 and BRO-2 producers were consistently higher than those for non-producers at inocula of 10(7) cfu/spot but overlapped with those for non-producers at lower inocula. A small beta-lactamase-related inoculum effect was seen with coamoxiclav; small inoculum effects also occurred with cefaclor and cefixime but were not related to enzyme presence or type. MICs of cefetamet were the least affected by the inoculum size. For all the compounds, the degree of correlation between MICs and the inhibition zones observed in disk diffusion tests was independent of the inoculum used in the MIC tests. These data suggest that high inocula should be used to determine MICs of ampicillin for M. catarrhalis but that this precaution is unnecessary with the cephalosporins tested or with coamoxiclav.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151675     DOI: 10.1099/00222615-40-4-252

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.

Authors:  A Ohno; Y Ishii; L Ma; K Yamaguchi
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 3.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

4.  Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.

Authors:  Eli Chan; Shufeng Zhou; Sahasranaman Srikumar; Wei Duan
Journal:  Pharm Res       Date:  2006-03-29       Impact factor: 4.200

5.  Moraxella Bacteremia in Cancer Patients.

Authors:  Shamra Zaman; John Greene
Journal:  Cureus       Date:  2021-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.